Physician profile
Robert Schweikert
NPI 1427015858
$1,233.17
in general payments reported to CMS, 2019-2025
9 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $65.37 · 2021: $231 · 2023: $285 · 2024: $98.93 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $323.99 | 2020-2025 | Aveir, Ensite Precision, Gallant |
| Stereotaxis INC | $291.96 | 2019 | |
| Medtronic, INC. | $219.33 | 2023-2024 | Arctic Front Advance, Pulseselect, Na |
| Cardiva Medical, INC. | $157.13 | 2019-2024 | Savvywire |
| Impulse Dynamics (USA) INC. | $147.52 | 2021 | |
| Atricure, INC. | $35.96 | 2023 | |
| Boston Scientific Corporation | $33.02 | 2019-2024 | Vigilant X4 Crt-D |
| Angiodynamics, INC. | $19.98 | 2025 | Alphavac |
| Elutia, INC. | $4.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schweikert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.